Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Eduardo Moreno-Aguilera"'
Autor:
Jesus Vera-Aguilera, Hindi Yousef, Diego Beltran-Melgarejo, Teng Hugh Teng, Ramos Jan, Mary Mok, Carlos Vera-Aguilera, Eduardo Moreno-Aguilera
Publikováno v:
Advances in Hematology, Vol 2016 (2016)
Anti-Xa test measures the activity of heparin against the activity of activated coagulation factor X; significant variability of anti-Xa levels in common clinical scenarios has been observed. Objective. To review the most common clinical settings in
Externí odkaz:
https://doaj.org/article/272d54d360fd4c4ea15fbe54b43b296d
Autor:
Mitchell S. Wachtel, Gary Ventolini, Jesus Vera-Aguilera, Diego Beltran, Raul Martinez-Zaguilan, Cynthia Villanueva-Ramos, Souad R. Sennoune, Eduardo Moreno-Aguilera, Carlos Vera-Aguilera, Armando Pérez-Torres
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 32(2)
Recent successes in the development of new therapies for metastatic melanoma, such as mitogen-activated protein kinase pathway inhibitors, anticytotoxic T lymphocyte-associated antigen-4, and programmed cell death protein 1/programmed cell death liga
Autor:
Luis Alfonso Ley-Marcial, Eduardo Moreno-Aguilera, Carlos Vera-Aguilera, Jesus Vera-Aguilera, Francisco Iván Galeana-Nogueda
Publikováno v:
Universidad Nacional Autónoma de México
UNAM
Redalyc-UNAM
Cirugía y Cirujanos (México) Num.3 Vol.85
UNAM
Redalyc-UNAM
Cirugía y Cirujanos (México) Num.3 Vol.85
ResumenAntecedentesEl primer caso de perforación intestinal por metástasis de cáncer pulmonar, fue reportado en 1957. Las metástasis intestinales se reportan hasta en el 1.8% de los casos. La presentación clínica más frecuente es la obstrucci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4af8b2222ed3047816966f39d5a16587
https://www.redalyc.org/articulo.oa?id=66250860011
https://www.redalyc.org/articulo.oa?id=66250860011
Autor:
Carlos Vera-Aguilera, Jesus Vera-Aguilera, Armando Pérez-Torres, Diego Monteverde-Suarez, Juan Carlos Hernaiz-Leonardo, Eduardo Moreno-Aguilera, Daniel Estrada-Bárcenas
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 28:682-690
The therapeutic efficacy of a synthetic parasite-derived peptide GK1, an immune response booster, was evaluated in a mouse melanoma model. This melanoma model correlates with human stage IIb melanoma, which is treated with wide surgical excision; a p
Autor:
Carlos Vera-Aguilera, Jesus Vera-Aguilera, Francisco Iván Galeana-Nogueda, Eduardo Moreno-Aguilera, Luis Alfonso Ley-Marcial
Publikováno v:
Cirugia y cirujanos. 85(3)
Background The first reported case of intestinal perforation secondary to metastatic lung carcinoma was reported in 1957. Intestinal metastases are present in up to 1.8% of the cases, with small bowel obstruction as the most common clinical presentat
Autor:
Gabriela, Obregón-Guerrero, José Luis, Martínez-Ordaz, Eduardo, Moreno-Aguilera, Martha, Ramírez-Martinez, Juan Francisco, Peña-García, Claudia, Pérez-Álvarez
Publikováno v:
Cirugia y cirujanos. 81(4)
Deep neck abscesses are major complications that arise of odontogenic, pharyngeal, or cervicofacial foci, mainly in patients with morbidities that facilitate the spread to other spaces. Many of them require surgical treatment, and an appropriate eval
Autor:
Andrés, Romero y Huesca, Francisco, Pérez-Chávez, Maria, Anota-Rivera, Adriana, Ortega-Alvarez, Jonathan, Avilés-Tabares, Karina, Espinoza-Cerón, Ernesto, Bautista-Vera, Eduardo, Moreno-Aguilera, Francisco Javier, Ponce-Landín, Arturo Javier, Lavín-Lozano, Julio, Ramírez-Bollas
Publikováno v:
Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion. 60(5)
The prehispanic medicines of Mexico are considered as testimony of the splendor of the Meso-American cultures; their great scientific advance and technical allowed them to accumulate a vast collection of clinical and pathological data based on the ob
Autor:
Daniel Estrada Barcenas, Jesus Vera Aguilera, Eduardo Moreno Aguilera, Juan Carlos Hernaiz Leonardo, Diego Monterverde Suarez, Armando Pérez Torres, Carlos Vera Aguilera
Publikováno v:
Molecular Cancer Therapeutics. 12:C240-C240
Purpose: The therapeutic efficacy of a synthetic parasite-derived peptide GK1, an immune response booster, was evaluated in a mouse melanoma model. This melanoma model correlates with human stage IIb melanoma, which is treated with wide surgical exci